They gave us a clue to the fact that there seemed to be too muck active effect in an earlier release where they said they were looking at a reduced MPL level pill for the human trials. At the time I mentioned that this seemed strange as humans generally are bigger than dogs so the dose/kg should be larger. Sounds like they found effect quite early on in the trial so all looking really good.
Less active ingredient = cheaper to make = more profit = Elanco even keener.
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome, page-26
-
- There are more pages in this discussion • 413 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.3¢ |
Change
-0.008(4.17%) |
Mkt cap ! $83.90M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.3¢ | $59.77K | 338.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 376984 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 25091 | 2 |
View Market Depth
| Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |